Implantica Expands RefluxStop Device Availability in Europe
Implantica has announced that its RefluxStop device is now available in Germany, the United Kingdom, Switzerland, Spain, Italy, France, Austria, Sweden, and Norway.
Implantica, a company focused on medical devices, has expanded the availability of its RefluxStop device across Europe. The CE-marked device is now obtainable in Germany, the United Kingdom, Switzerland, Spain, Italy, France, Austria, Sweden, and Norway.
The RefluxStop device is designed to address gastroesophageal reflux disease, a common digestive condition. Its CE marking signifies compliance with European health and safety standards.
Availability in the United States and other countries is more restricted, with the RefluxStop not being offered for sale in all regions. For further details, customers are advised to contact the company's customer support via email.
This market expansion indicates Implantica's strategy to provide treatment options for patients suffering from reflux disease to a broader European consumer base.